Accessibility Menu
 

Septerna

(NASDAQ) SEPN

Current Price$23.63
Market Cap$1.06B
Since IPO (2024)+10%
5 YearN/A
1 Year+231%
1 Month-3%

Septerna Financials at a Glance

Market Cap

$1.06B

Revenue (TTM)

$45.95M

Net Income (TTM)

$48.88M

EPS (TTM)

$-1.11

P/E Ratio

-21.22

Dividend

$0.00

Beta (Volatility)

1.33 (Average)

Price

$23.63

Volume

7,806

Open

$23.45

Previous Close

$23.63

Daily Range

$23.24 - $24.02

52-Week Range

$6.42 - $32.63

SEPN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Septerna

Industry

Pharmaceuticals

Employees

130

CEO

Jeffrey T. Finer, MD, PhD

Headquarters

South San Francisco, CA 94080, US

SEPN Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-1%

Net Income Margin

-1%

Return on Equity

-12%

Return on Capital

-13%

Return on Assets

-8%

Earnings Yield

-4.71%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.06B

Shares Outstanding

44.91M

Volume

7.81K

Avg. Volume

318.61K

Financials (TTM)

Gross Profit

$45.95M

Operating Income

$80.80M

EBITDA

$79.19M

Operating Cash Flow

$110.19M

Capital Expenditure

$518.00K

Free Cash Flow

$109.67M

Cash & ST Invst.

$391.09M

Total Debt

$23.63M

Septerna Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$24.12M

+11276.4%

Gross Profit

$24.12M

+11276.4%

Gross Margin

100.00%

N/A

Market Cap

$1.06B

N/A

Market Cap/Employee

$14.14M

N/A

Employees

75

N/A

Net Income

$10.74M

+48.0%

EBITDA

$15.62M

+35.8%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$367.46M

+12.9%

Accounts Receivable

$10.36M

+821.4%

Inventory

$0.00

N/A

Long Term Debt

$21.41M

-9.4%

Short Term Debt

$2.21M

+19.5%

Return on Assets

-8.20%

N/A

Return on Invested Capital

-13.41%

N/A

Free Cash Flow

$15.05M

+30.2%

Operating Cash Flow

$14.99M

+28.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MRVIMaravai LifeSciences Holdings, Inc.
$3.73+1.36%
EYPTEyePoint Pharmaceuticals, Inc.
$13.34+1.06%
FTREFortrea Holdings Inc.
$12.18+5.91%
BCAXBicara Therapeutics Inc. Common Stock
$21.67+0.42%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
AAPLApple
$280.14+0.03%
TQQQProShares Trust - ProShares UltraPro Qqq
$65.30+0.03%

Questions About SEPN

What is the current price of Septerna?

Septerna is trading at $23.63 per share.

What is the 52-week range for Septerna?

Over the past 52 weeks, Septerna has traded between $6.42 and $32.63.

How much debt does Septerna have?

As of the most recent reporting period, Septerna reported total debt of $23.63M.

How much cash does Septerna have on hand?

Septerna reported $120.72M in cash and cash equivalents in its most recent financial results.

What is Septerna’s dividend yield?

Septerna does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.